A comparison of 14 antibodies for the biochemical detection of the cystic fibrosis transmembrane conductance regulator protein

Molecular and Cellular Probes

Volumn 18, Issue 4, 2004, Pages 235-242

  Farinha, Carlos M ^a,b   Mendes, Filipa ^a   Roxo Rosa, Mónica ^a,b   Penque, Deborah ^a   Amaral, Margarida D ^a,b  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^b UNIVERSITY OF LISBON   (Portugal)

Author keywords

Aa, aminoacid; Ab, antibody; ABC, ATP binding cassette; Antibody; AT, alternative initiation (site); BHK, baby hamster kidney (cells); CF, cystic fibrosis; CFTR; CFTR, CF transmembrane conductance regulator; Immunoprecipitation; Western blot

Indexed keywords

ANTIBODY; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ACCURACY; ANIMAL CELL; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; WESTERN BLOTTING;

ANIMALS; ANTIBODIES; BLOTTING, WESTERN; CELLS, CULTURED; CHO CELLS; CRICETINAE; CRICETULUS; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; HUMANS; IMMUNOPRECIPITATION;

CRICETINAE;

EID: 3242674336     PISSN: 08908508     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcp.2004.03.005     Document Type: Article

References (37)

1. Collins F.S. Cystic fibrosis: molecular biology and therapeutic implications. Science. 256:1992;774-779
2. Cheng S.H., Rich D.P., Marshall J., Gregory R.J., Welsh M.J., Smith A.E. Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel. Cell. 66:1991;1027-1036
3. Cheng S.H., Gregory R.J., Marshall J., et al. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell. 63:1990;827-834
4. Sarkadi B., Bauzon D., Huckle W.R., et al. Biochemical characterization of the cystic fibrosis transmembrane conductance regulator in normal and cystic fibrosis epithelial cells. J Biol Chem. 267:1992;2087-2095
5. Zeitlin P.L., Crawford I., Lu L., et al. CFTR protein expression in primary and cultured epithelia. Proc Natl Acad Sci USA. 89:1992;344-347
6. Wei X., Eisman R., Xu J., et al. Turnover of the cystic fibrosis transmembrane conductance regulator (CFTR): slow degradation of wild-type and delta F508 CFTR in surface membrane preparations of immortalized airway epithelial cells. J Cell Physiol. 168:1996;373-384
7. Kalin N., Claass A., Sommer M., Puchelle E., Tummler B. DeltaF508 CFTR protein expression in tissues from patients with cystic fibrosis. J Clin Invest. 103:1999;1379-1389
8. Penque D., Mendes F., Beck S., et al. Cystic fibrosis F508del patients have apically localized CFTR in a reduced number of airway cells. Lab Invest. 80:2000;857-868
9. Doucet L., Mendes F., Montier T., et al. Applicability of different antibodies for the immunohistochemical localization of CFTR in respiratory and intestinal tissues of human and murine origin. J Histochem Cytochem. 51:2003;1191-1199
10. Carvalho-Oliveira I., Efthymiadou A., Malhó R., et al. CFTR localization in native airway cells and cell lines expressing wild-type or F508del-CFTR by a panel of different antibodies. J Histochem Cytochem. 52:2003;193-203
11. Tabcharani J.A., Chang X.B., Riordan J.R., Hanrahan J.W. Phosphorylation-regulated Cl-channel in CHO cells stably expressing the cystic fibrosis gene. Nature. 352:1991;628-631
12. Zhang F., Kartner N., Lukacs G.L. Limited proteolysis as a probe for arrested conformational maturation of delta F508 CFTR. Nat Struct Biol. 5:1998;180-183
13. Cozens A.L., Yezzi M.J., Chin L., et al. Characterization of immortal cystic fibrosis tracheobronchial gland epithelial cells. Proc Natl Acad Sci USA. 89:1992;5171-5175
14. Fogh J., Wright W.C., Loveless J.D. Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J Natl Cancer Inst. 58:1977;209-214
15. Brezillon S., Dupuit F., Hinnrasky J., et al. Decreased expression of the CFTR protein in remodeled human nasal epithelium from non-cystic fibrosis patients. Lab Invest. 72:1995;191-200
16. Morris A.P., Cunningham S.A., Tousson A., Benos D.J., Frizzell R.A. Polarization-dependent apical membrane CFTR targeting underlies cAMP-stimulated Cl-secretion in epithelial cells. Am J Physiol. 266:1994;C254-C268
17. Montrose-Rafizadeh C., Blackmon D.L., Hamosh A., et al. Regulation of cystic fibrosis transmembrane conductance regulator (CFTR) gene transcription and alternative RNA splicing in a model of developing intestinal epithelium. J Biol Chem. 267:1992;19299-19305
18. Zeitlin P.L., Lu L., Rhim J., et al. A cystic fibrosis bronchial epithelial cell line: immortalization by adeno-12-SV40 infection. Am J Respir Cell Mol Biol. 4:1991;313-319
19. Fogh J., Trempe G. Fogh J. Human tumor cells in vitro. 1975;115-159 Plenum Press, New York
20. Kunzelmann K., Schwiebert E.M., Zeitlin P.L., Kuo W.L., Stanton B.A., Gruenert D.C. An immortalized cystic fibrosis tracheal epithelial cell line homozygous for the delta F508 CFTR mutation. Am J Respir Cell Mol Biol. 8:1993;522-529
21. Olsen J.C., Sechelski J. Use of sodium butyrate to enhance production of retroviral vectors expressing CFTR cDNA. Hum Gene Ther. 6:1995;1195-1202
22. Cheng S.H., Fang S.L., Zabner J. Functional activation of the cystic fibrosis trafficking mutant delta F508-CFTR by overexpression. Am J Physiol. 268:1995;L615-L624
23. Yeivin A., Tang D.C., Taylor M.W. Sodium butyrate selectively induces transcription of promoters adjacent to the MoMSV viral enhancer. Gene. 116:1992;159-164
24. Crawford I., Maloney P.C., Zeitlin P.L., et al. Immunocytochemical localization of the cystic fibrosis gene product CFTR. Proc Natl Acad Sci USA. 88:1991;9262-9266
25. Meacham G.C., Lu Z., King S., Sorscher E., Tousson A., Cyr D.M. The Hdj-2/Hsc70 chaperone pair facilitates early steps in CFTR biogenesis. EMBO J. 18:1999;1492-1505
26. Claass A., Sommer M., De Jonge H., Kalin N., Tummler B. Applicability of different antibodies for immunohistochemical localization of CFTR in sweat glands from healthy controls and from patients with cystic fibrosis. J Histochem Cytochem. 48:2000;831-837
27. Dormer R.L., McNeilly C.M., Morris M.R., et al. Localisation of wild-type and DeltaF508-CFTR in nasal epithelial cells. Pflugers Arch. 443:(suppl 1):2001;S117-S120
28. French P.J., van Doorninck J.H., Peters R.H., et al. A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo. J Clin Invest. 98:1996;1304-1312
29. Kartner N., Augustinas O., Jensen T.J., Naismith A.L., Riordan J.R. Mislocalization of delta F508 CFTR in cystic fibrosis sweat gland. Nat Genet. 1:1992;321-327
30. Johnston J.A., Ward C.L., Kopito R.R. Aggresomes: a cellular response to misfolded proteins. J Cell Biol. 143:1998;1883-1898
31. Jensen T.J., Loo M.A., Pind S., Williams D.B., Goldberg A.L., Riordan J.R. Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell. 83:1995;129-135
32. Chang X.B., Cui L., Hou Y.X., et al. Removal of multiple arginine-framed trafficking signals overcomes misprocessing of delta F508 CFTR present in most patients with cystic fibrosis. Mol Cell. 4:1999;137-142
33. Zeitlin P.L. Novel pharmacologic therapies for cystic fibrosis. J Clin Invest. 103:1999;447-452
34. Shen B.Q., Finkbeiner W.E., Wine J.J., Mrsny R.J., Widdicombe J.H. Calu-3: a human airway epithelial cell line that shows cAMP-dependent Cl-secretion. Am J Physiol. 266:1994;L493-L501
35. Cozens A.L., Yezzi M.J., Kunzelmann K., et al. CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am J Respir Cell Mol Biol. 10:1994;38-47
36. Wigley W.C., Fabunmi R.P., Lee M.G., et al. Dynamic association of proteasomal machinery with the centrosome. J Cell Biol. 145:1999;481-490
37. Sato S., Ward C.L., Kopito R.R. Cotranslational ubiquitination of cystic fibrosis transmembrane conductance regulator in vitro. J Biol Chem. 273:1998;7189-7192